BioLife Solutions, Inc. (FRA:BJX1)

BioLife Solutions Statistics

Total Valuation

FRA:BJX1 has a market cap or net worth of EUR 1.05 billion. The enterprise value is 985.55 million.

Market Cap	1.05B
Enterprise Value	985.55M

Important Dates

The next estimated earnings date is Friday, March 6, 2026.

Earnings Date	Mar 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	48.15M
Shares Outstanding	n/a
Shares Change (YoY)	+3.88%
Shares Change (QoQ)	+1.94%
Owned by Insiders (%)	2.88%
Owned by Institutions (%)	87.34%
Float	40.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	161.16
PS Ratio	12.33
PB Ratio	3.49
P/TBV Ratio	9.22
P/FCF Ratio	123.02
P/OCF Ratio	73.31
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-360.68
EV / Sales	11.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	115.21

Financial Position

The company has a current ratio of 4.66, with a Debt / Equity ratio of 0.06.

Current Ratio	4.66
Quick Ratio	3.31
Debt / Equity	0.06
Debt / EBITDA	11.44
Debt / FCF	2.06
Interest Coverage	-189.09

Financial Efficiency

Return on equity (ROE) is -5.25% and return on invested capital (ROIC) is -0.77%.

Return on Equity (ROE)	-5.25%
Return on Assets (ROA)	-0.73%
Return on Invested Capital (ROIC)	-0.77%
Return on Capital Employed (ROCE)	-1.24%
Revenue Per Employee	536,810
Profits Per Employee	-17,185
Employee Count	159
Asset Turnover	0.26
Inventory Turnover	1.19

Taxes

In the past 12 months, FRA:BJX1 has paid 209,666 in taxes.

Income Tax	209,666
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-18.75%
50-Day Moving Average	22.63
200-Day Moving Average	21.15
Relative Strength Index (RSI)	52.07
Average Volume (20 Days)	43

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.78

Income Statement

In the last 12 months, FRA:BJX1 had revenue of EUR 85.35 million and -2.73 million in losses. Loss per share was -0.06.

Revenue	85.35M
Gross Profit	54.87M
Operating Income	-3.87M
Pretax Income	-14.98M
Net Income	-2.73M
EBITDA	-1.62M
EBIT	-3.87M
Loss Per Share	-0.06

Balance Sheet

The company has 67.29 million in cash and 17.62 million in debt, giving a net cash position of 66.24 million.

Cash & Cash Equivalents	67.29M
Total Debt	17.62M
Net Cash	66.24M
Net Cash Per Share	n/a
Equity (Book Value)	301.49M
Book Value Per Share	6.29
Working Capital	84.74M

Cash Flow

In the last 12 months, operating cash flow was 14.36 million and capital expenditures -5.80 million, giving a free cash flow of 8.55 million.

Operating Cash Flow	14.36M
Capital Expenditures	-5.80M
Free Cash Flow	8.55M
FCF Per Share	n/a

Margins

Gross margin is 64.28%, with operating and profit margins of -4.53% and -3.20%.

Gross Margin	64.28%
Operating Margin	-4.53%
Pretax Margin	-17.55%
Profit Margin	-3.20%
EBITDA Margin	-1.90%
EBIT Margin	-4.53%
FCF Margin	10.02%

Dividends & Yields

FRA:BJX1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.88%
Shareholder Yield	-3.88%
Earnings Yield	-0.26%
FCF Yield	0.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:BJX1 has an Altman Z-Score of 17.17 and a Piotroski F-Score of 4.

Altman Z-Score	17.17
Piotroski F-Score	4